196 related articles for article (PubMed ID: 31637677)
1. Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy.
Alomari G; Al-Trad B; Hamdan S; Aljabali A; Al-Zoubi M; Bataineh N; Qar J; Tambuwala MM
Drug Deliv Transl Res; 2020 Feb; 10(1):216-226. PubMed ID: 31637677
[TBL] [Abstract][Full Text] [Related]
2. Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin-induced type 1 diabetes in rats.
Alomari G; Al-Trad B; Hamdan S; Aljabali AAA; Al Zoubi MS; Al-Batanyeh K; Qar J; Eaton GJ; Alkaraki AK; Alshaer W; Haifawi S; Jemon K; Chellappan DK; Dua K; Tambuwala MM
IET Nanobiotechnol; 2021 Jul; 15(5):473-483. PubMed ID: 34694755
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
4. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
5. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
Zhang X; Song Z; Guo Y; Zhou M
Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
[TBL] [Abstract][Full Text] [Related]
6. Panax Notoginseng Ameliorates Podocyte EMT by Targeting the Wnt/β-Catenin Signaling Pathway in STZ-Induced Diabetic Rats.
Xie L; Zhai R; Chen T; Gao C; Xue R; Wang N; Wang J; Xu Y; Gui D
Drug Des Devel Ther; 2020; 14():527-538. PubMed ID: 32103895
[TBL] [Abstract][Full Text] [Related]
7. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Zhou G; Cheung AK; Liu X; Huang Y
Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
[TBL] [Abstract][Full Text] [Related]
8. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
Kim SI; Han DC; Lee HB
J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
[TBL] [Abstract][Full Text] [Related]
10. The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats.
Ertürküner SP; Başar M; Tunçdemir M; Seçkin İ
Pharmacol Rep; 2014 Apr; 66(2):279-87. PubMed ID: 24911082
[TBL] [Abstract][Full Text] [Related]
11. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.
Deepa B; Venkatraman Anuradha C
Toxicol Mech Methods; 2013 May; 23(4):223-34. PubMed ID: 23193997
[TBL] [Abstract][Full Text] [Related]
12. Nigella sativa oil and thymoquinone ameliorate albuminuria and renal extracellular matrix accumulation in the experimental diabetic rats.
Al-Trad B; Al-Batayneh K; El-Metwally S; Alhazimi A; Ginawi I; Alaraj M; Alkofahi E; Aljumaili O; Kosba A
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2680-8. PubMed ID: 27383323
[TBL] [Abstract][Full Text] [Related]
13. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.
Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.
Xiao T; Guan X; Nie L; Wang S; Sun L; He T; Huang Y; Zhang J; Yang K; Wang J; Zhao J
Mol Cell Biochem; 2014 Sep; 394(1-2):145-54. PubMed ID: 24850187
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
17. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.
Zhang H; Saha J; Byun J; Schin M; Lorenz M; Kennedy RT; Kretzler M; Feldman EL; Pennathur S; Brosius FC
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1071-81. PubMed ID: 18667486
[TBL] [Abstract][Full Text] [Related]
19. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
